Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost

Daptomycin Resistance in Clinical MRSA Strains Is Associated with a High Biological Fitness Cost

Daptomycin remains as one of the main treatment options for Methicillin-Resistant Staphylococcus aureus (MRSA). Sporadic resistance cases reported in patients treated with either daptomycin or glycopeptides are a growing concern. In a previous study, we described a clinical case of a patient with a...

Full description

Bibliographic Details
Main Authors: Melanie Roch, Paula Gagetti, James Davis, Paola Ceriana, Laura Errecalde, Alejandra Corso, Adriana E. Rosato
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-12-01
Series:Frontiers in Microbiology
Subjects:
MRSA
daptomycin
biological cost
in vivo
Online Access:http://journal.frontiersin.org/article/10.3389/fmicb.2017.02303/full

Similar Items

Similar Items